iXCells Biotechnologies Announces Strategic Initiatives to Drive Continued Growth

SAN DIEGO–(BUSINESS WIRE)–iXCells Biotechnologies (the “Company”), a provider of induced pluripotent stem cells (iPSCs), differentiation services, primary cells, media and reagents for drug discovery and development, today announced key growth initiatives. The Company is implementing a cloud-based ERP solution powered by Oracle NetSuite® that will integrate workflows and create operational efficiencies. “Our rapid growth in recent years has hastened the need for a new solution capable of hand
Click here to view original post